B
Remote · United States
BeiGene
BeiGene is a global oncology company developing medicines for cancer and blood disorders, with regulatory approvals in over 75 countries and clinical trials spanning more than 45 countries.
BeiGene, which describes itself as BeOne Medicines, is a global oncology company with a team of approximately 12,000 people spread across over 45 office locations on six continents. The company focuses on oncology and hematology, with expertise in treating solid tumors and developing therapies such as protein degradation with CDACs and antibody drug conjugates. Its research team numbers more than 1,200 members.
The company has achieved regulatory approval in more than 75 countries for three of its internally developed medicines. It has initiated over 175 clinical trials across 45+ countries and regions, enrolling more than 30,000 patients. BeiGene is publicly traded.
The company states its core values as Patients First, Driving Excellence, Bold Ingenuity, and Collaborative Spirit. It describes its culture as featuring non-hierarchical teamwork and a willingness to challenge the status quo.